Enter multiple symbols separated by commas

Amgen Names Bradway to Replace Nanula as Chief Financial Officer

Amgen, theworld's largest biotechnology company, said after U.S. markets closed Tuesday that it appointed Robert Bradway as chief financial officer.

Bradway replaces Richard Nanula, who is leaving the company to pursue other opportunities.

Bradway, 44, joined Amgen in 2006 as vice president, operations strategy. Prior to joining Amgen, he spent 18 years at Morgan Stanley.

Nanula will remain at Amgen for the next 90 days to assist in the transition.

Contact U.S. News


    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

U.S. Video

  • A job search tool that reads your mind

    Pymetrics, a neuroscience-based applicant screening system, uses online games to measure job seekers' willingness to take risks, their skepticism, motivations and flexibility. The platform then matches applicants with companies looking to hire, saving the companies time and resources spent on sifting through resumes, interviewing and hiring.

  • Volatile stock market pattern likely to continue

    U.S. stock futures were lower in early trading, after Wednesday's rally on Wall Street. Investors are looking ahead to key economic data.

  • Hormel CEO: Excited to enter natural & organic category

    Jeffrey Ettinger, Hormel Foods chairman and CEO, discusses the company's organic food play and acquisition of Applegate Farms, with Mad Money's Jim Cramer.